TANDEM DIABETES CARE INC (TNDM)

US8753722037 - Common Stock

35.24  -0.32 (-0.9%)

After market: 35.24 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
702.8M
40.90%		801.2M
14.00%		747.718M
-6.68%		862.22M
15.31%
EBITDA
YoY % growth
36.5M
1,360.00%		-78.5M
-315.07%		-217.515M
-177.09%		1.822M
100.84%		N/AN/AN/AN/A
EBIT
YoY % growth
22.7M
383.75%		-92.8M
-508.81%		-233.23M
-151.33%		-119.415M
48.80%
Operating Margin
3.23%-11.58%-31.19%-13.85%
EPS
YoY % growth
0.23
136.51%		-0.99
-530.43%		-3.12
-215.15%		-1.63
47.90%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.77
59.75%
Revenue
Q2Q % growth		177.5M
4.78%
EBITDA
Q2Q % growth		-25.202M
EBIT
Q2Q % growth		-54.861M
57.07%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.27
-8.00%		-0.26-0.01-3.93%
Q3 2023
Q2Q % growth		 -0.38
-40.74%		-0.34-0.04-10.81%
Q2 2023
Q2Q % growth		 -0.55
-129.17%		-0.54-0.01-1.38%
Q1 2023
Q2Q % growth		 -1.92
-734.78%		-0.53-1.39-264.32%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 196.796M
-10.75%		206.81M-10.014M-4.84%
Q3 2023
Q2Q % growth		 185.6M
-9.24%		196.56M-10.96M-5.58%
Q2 2023
Q2Q % growth		 195.9M
-2.20%		201.31M-5.41M-2.69%
Q1 2023
Q2Q % growth		 169.4M
-3.70%		173.63M-4.23M-2.44%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.38% -62.74% 0.43% -27.39%
Revenue-0.12% -6.78% 0.07% 0.57%